PT Central Proteina Prima Tbk
PT Central Proteina Prima Tbk, together with its subsidiaries, operates as an integrated aquaculture shrimp and foods producer company in Indonesia and internationally. It operates through Feeds business, Food business, and Others segments. The company engages in industry, livestock and agriculture, trading, farming, hatchery, and trading and services. It offers shrimp feed, fish feed, cat food, … Read more
PT Central Proteina Prima Tbk (4PT) - Total Liabilities
Latest total liabilities as of June 2025: €2.98 Trillion EUR
Based on the latest financial reports, PT Central Proteina Prima Tbk (4PT) has total liabilities worth €2.98 Trillion EUR as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
PT Central Proteina Prima Tbk - Total Liabilities Trend (2013–2024)
This chart illustrates how PT Central Proteina Prima Tbk's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
PT Central Proteina Prima Tbk Competitors by Total Liabilities
The table below lists competitors of PT Central Proteina Prima Tbk ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Tontek Design Technology Ltd
TWO:5487
|
Taiwan | NT$44.10 Million |
|
IFS Capital (Thailand) Public Company Limited
BK:IFS
|
Thailand | ฿2.44 Billion |
|
Tsky Co.,Ltd
TWO:6784
|
Taiwan | NT$67.88 Million |
|
Huddlestock Fintech As
OL:HUDL
|
Norway | Nkr52.16 Million |
|
Study King Co., Ltd.
TWO:6780
|
Taiwan | NT$76.88 Million |
|
Ekadharma International Tbk
JK:EKAD
|
Indonesia | Rp97.02 Billion |
Liability Composition Analysis (2013–2024)
This chart breaks down PT Central Proteina Prima Tbk's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.07 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.77 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.44 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how PT Central Proteina Prima Tbk's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for PT Central Proteina Prima Tbk (2013–2024)
The table below shows the annual total liabilities of PT Central Proteina Prima Tbk from 2013 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €3.14 Trillion | -8.70% |
| 2023-12-31 | €3.44 Trillion | -5.89% |
| 2022-12-31 | €3.65 Trillion | +1.81% |
| 2021-12-31 | €3.59 Trillion | -36.16% |
| 2020-12-31 | €5.62 Trillion | -0.92% |
| 2019-12-31 | €5.67 Trillion | -3.85% |
| 2018-12-31 | €5.90 Trillion | -32.88% |
| 2017-12-31 | €8.79 Trillion | +23.03% |
| 2016-12-31 | €7.14 Trillion | +0.54% |
| 2015-12-31 | €7.10 Trillion | +14.93% |
| 2014-12-31 | €6.18 Trillion | +5.27% |
| 2013-12-31 | €5.87 Trillion | -- |